RhumbLine Advisers’s Castle Biosciences CSTL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $996K | Sell |
|
|||||
|
2025
Q2 | $927K | Buy |
|
|||||
|
2025
Q1 | $784K | Sell |
|
|||||
|
2024
Q4 | $1.06M | Sell |
|
|||||
|
2024
Q3 | $1.17M | Sell |
|
|||||
|
2024
Q2 | $912K | Buy |
|
|||||
|
2024
Q1 | $862K | Buy |
|
|||||
|
2023
Q4 | $818K | Buy |
|
|||||
|
2023
Q3 | $639K | Buy |
|
|||||
|
2023
Q2 | $512K | Sell |
|
|||||
|
2023
Q1 | $893K | Buy |
|
|||||
|
2022
Q4 | $892K | Buy |
|
|||||
|
2022
Q3 | $978K | Buy |
|
|||||
|
2022
Q2 | $752K | Buy |
|
|||||
|
2022
Q1 | $984K | Buy |
|
|||||
|
2021
Q4 | $896K | Sell |
|
|||||
|
2021
Q3 | $1.41M | Buy |
|
|||||
|
2021
Q2 | $1.5M | Buy |
|
|||||
|
2021
Q1 | $993K | Buy |
|
|||||
|
2020
Q4 | $907K | Buy |
|
|||||
|
2020
Q3 | $642K | Sell |
|
|||||
|
2020
Q2 | $481K | Buy |
|
|||||
|
2020
Q1 | $276K | Buy |
|